NMR solution structure and receptor peptide binding of the CC chemokine eotaxin-2

被引:55
作者
Mayer, KL [1 ]
Stone, MJ [1 ]
机构
[1] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA
关键词
D O I
10.1021/bi000523j
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human CC chemokine eotaxin-2 is a specific agonist for the chemokine receptor CCR3 and may play a role in the recruitment of eosinophils in allergic diseases and parasitic infections. We report the solution structure of eotaxin-2 determined using heteronuclear and triple resonance NMR methods. A family of 20 structures was calculated by hybrid distance geometry-simulated annealing from 854 NOE distance restraints, 48 dihedral angle restraints, and 12 hydrogen bond restraints. The structure of eotaxin-2 (73 amino acid residues) consists of a helical turn (residues 17-20) followed by a 3-stranded antiparallel beta-sheet (residues 22-26, 37-41, and 44-49) and an alpha-helix (residues 54-66). The N-loop (residues 9-16) is packed against both the sheet and the helix with the two conserved disulfide bonds tethering the N-terminal/N-loop region to the beta-sheet. The average backbone and heavy atom rmsd values of the 20 structures (residues 7-66) are 0.52 and 1.13 Angstrom, respectively. A linear peptide corresponding to the N-terminal region of CCR3 binds to eotaxin-2, inducing concentration-dependent chemical shift changes or line broadening of many residues. The distribution of these residues suggests that the peptide binds into an extended groove located at the interface between the N-loop and the beta 2-beta 3 hairpin. The receptor peptide may also interact with the N-terminus of the chemokine and part of the alpha-helix. Comparison of the eotaxin-2 structure with those of related chemokines indicates several structural features that may contribute to receptor specificity.
引用
收藏
页码:8382 / 8395
页数:14
相关论文
共 86 条
[1]   Human chemokines: An update [J].
Baggiolini, M ;
Dewald, B ;
Moser, B .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :675-705
[2]   A new class of membrane-bound chemokine with a CX(3)C motif [J].
Bazan, JF ;
Bacon, KB ;
Hardiman, G ;
Wang, W ;
Soo, K ;
Rossi, D ;
Greaves, DR ;
Zlotnik, A ;
Schall, TJ .
NATURE, 1997, 385 (6617) :640-644
[3]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[4]  
BRUNGER AT, 1993, XPLOR VERSION 3 1 SY
[5]  
CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128
[6]   3-DIMENSIONAL SOLUTION STRUCTURE OF ESCHERICHIA-COLI PERIPLASMIC CYCLOPHILIN [J].
CLUBB, RT ;
FERGUSON, SB ;
WALSH, CT ;
WAGNER, G .
BIOCHEMISTRY, 1994, 33 (10) :2761-2772
[7]   MAPPING THE BINDING SURFACE OF INTERLEUKIN-8 COMPLEXED WITH AN N-TERMINAL FRAGMENT OF THE TYPE-1 HUMAN INTERLEUKIN-8 RECEPTOR [J].
CLUBB, RT ;
OMICHINSKI, JG ;
CLORE, GM ;
GRONENBORN, AM .
FEBS LETTERS, 1994, 338 (01) :93-97
[8]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[9]   Backbone dynamics of the human CC chemokine eotaxin: Fast motions, slow motions, and implications for receptor binding [J].
Crump, MP ;
Spyracopoulos, L ;
Lavigne, P ;
Kim, KS ;
Clark-Lewis, I ;
Sykes, BD .
PROTEIN SCIENCE, 1999, 8 (10) :2041-2054
[10]   Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1 [J].
Crump, MP ;
Gong, JH ;
Loetscher, P ;
Rajarathnam, K ;
Amara, A ;
Arenzana-Seisdedos, F ;
Virelizier, JL ;
Baggiolini, M ;
Sykes, BD ;
Clark-Lewis, I .
EMBO JOURNAL, 1997, 16 (23) :6996-7007